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Lajya Devi Goyal1, Sharanjit Kaur2* and Kanwardeep Kawatra3Abstract
Mixed germ cell tumours of the ovary are malignant neoplasms of the ovary comprising of two or more types of germ
cell components. Most of the malignant mixed germ cell tumours consists of dysgerminoma accompanied by
endodermal sinus tumours, immature teratoma or choriocarcinoma. There are only few case reports of mixed germ cell
tumours with different combinations of malignant components.
We report a very rare case of mixed germ cell tumours consisted of malignant components of endodermal sinus tumour,
emryonal carcinoma, and benign component of teratomatuos and trophoblastic differentiation. This is the first case report
in the literature with both benign and malignant component of type described to best of our knowledge.
Patient was an 18 year old girl, who presented with pain abdomen, abdominal mass and irregular bleeding. Ultrasound
and CT scan showed a huge mass with solid and cystic component. Tumour markers i.e alpha feto- protein (AFP),
human chorionic gonadotropin (hCG), lactate dehydrogenate (LDH) and Ca-125 were raised. We performed fertility
sparing surgery by preserving one ovary, tube and uterus.
Conclusion: Malingnant mixed germ cell tumours of ovary are highly aggressive neoplasm and early intervention and
fertility sparing surgery is required for any adolescent girl presenting with rapidly enlarging pelvic mass.
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Ovarian germ cell tumours arise from primordial germ cell
derived from the embryonal gonads. Malignant germ cell
tumour comprise less than 5% of all ovarian neoplasms.
The incidence range from 1 to 6% in west and from 8 to
19% in Asia [1]. The most common form of malignant
germ cell tumours are dysgerminoma (80%), endodermal
sinus tumour (EST) (70%), and immature teratoma (53%)
reported in a series [2]. Embryonal carcinoma, choriocar-
cinoma and polyembryoma are very rare type of germ cell
tumour. Malignant mixed germ cell tumour is a type of
tumour that consists of two or more malignant germ
cell component. Most common combination reported is
dysgerminoma and EST [2] and rarer component include
embryonal carcinoma and immature terotoma [3,4].
Tumour markers such as AFP, hCG and LDH contribute to
the diagnosis, prognosis and follow-up of the disease. We
report a case of very rare mixed germ cell tumour consisted* Correspondence: jitsharan28@gmail.com
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unless otherwise stated.of both malignant and benign component i:e EST, embry-
onal carcinoma, mature teratomatuos components and
trophoblastic differentiation. There are only few case re-
ports of mixed germ cell tumour with different combina-
tions of malignant components but this is the first case
report in the literature with both benign and malignant
component of type described to the best of our knowledge.Case report
An 18 year old girl presented with chief complaint of ab-
dominal mass and pain of one month duration. She also
complained of fever and poor appetite. Her menstrual
history revealed that she had experienced menarche at
the age of 12 and her cycles were regular with normal
flow in the past but had irregular bleeding in last two cy-
cles. Her physical examination revealed severe pallor
and pedal edema. Her vital signs showed tachycardia
(pulse rate 120/min), blood pressure 100/70 mm Hg and
respiratory rate 18/min. On abdominal examination a
huge mass up to the level of xiphisternum could be pal-
pated. There was no guarding or rebound tenderness.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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count 7700, platelet count 437 × 103 and on peripheral
blood film there was microcytic hypochromic type of
anemia. Serum biochemistry was normal. USG revealed
a huge solid cystic mass occupying the whole abdomen.
Right ovary was not separately visualised from the mass
but left ovary was normal looking. There was no evidence
of free fluid in abdomen. CT scan revealed no retroperi-
toneal lymphadenopathy. Tumour markers levels were
CA-125 -259.3 IU/ml, Carcinoembroyonic antigen (CEA)
4.3 ng/ml alpha feto protein (AFP) 489.9 ng/ml, human
chorionic gonadotropic levels (hCG) 3751.5 IU/ml and
Lactate dehydrogenate (LDH) 3600 IU/ml.
Intraoperatively there was a huge mass arising from
right sided ovary with intact capsule. There was no free
fluid in the abdominal cavity and peritoneal washings
were taken. Abdominal cavity was explored and there
was no evidence of malignant disease elsewhere. Left-
sided ovary and uterus was normal looking. Tumour was
removed and biopsy was taken from left ovary and infraco-
lic omentectomy and pelvic and paraaortic lymhphadenect-
omy was done for staging of the tumour. Frozen section
could not be done as the machine was out of order.
On gross examination (Figure 1) tumour measured
25 × 24 × 11 cm and weighed 4800 gms. External surface
was smooth and bosselated with an intact capsule. Serial
cut sections revealed a tumour with solid and cystic var-
iegated cut surface showing dark-brown, grey-brown,
myxoid and necrotic areas. Microscopy showed a germ
cell tumour of variable composition. Predominant com-
ponent was that of yolk sac tumour showing reticular
(Figure 2a) and microcystic (Figure 2b) areas with
Schiller-Duval bodies (Figure 2c). Several multinucleated
trophoblastic giant cells were also present (Figure 2d).
Along with this, there were mature teratomatous com-
ponents in the form of squamous islands (Figure 3a), cys-
tic spaces lined by mucinous epithelium (Figure 3c) andFigure 1 Photograph showing gross tumour.hepatocytes (Figure 3b). Some areas also showed embry-
onal carcinoma (Figure 3d). No extra capsular invasion
was seen. Lymph nodes and omentum were also free of
tumour.
Final histopathological diagnosis was: Mixed germ cell
tumour with components of yolk sac tumour, mature
teratoma, embryonal carcinoma and trophoblastic giant
cells.
Patient was discharged in satisfactory condition and
received four cycles of bleomycin, etoposide and cis-
platin combination chemotherapy. Patient is on follow
up and on 3 and 6 month follow up patient did not
show any evidence of recurrence.
Discussion
Rare combination of uncommon germ cell components,
huge size and capsule being intact, very high levels of
tumour markers makes this case unusual.
Most mixed germ cell tumour consist of combination
of dysgerminoma with endodermal sinus tumour ac-
counting for one-third of the cases [2]. Other combin-
ation include choriocarcinoma and immature teratoma
in decreasing order of frequency. Cases of mixed germ
cell tumour of endodermal sinus tumour and emryonal
carcinoma are rare and tumours with component of be-
nign variety of trophoblastic and mature teratomatous
combination are exceptional. Recently a rare combin-
ation of mixed germ cell and granulose cell tumour has
been reported in the literature [5].
The average age of presentation of germ cell tumour is
13.8 years (4–27 years) [6]. Most common clinical
presentation includes abdominal mass with or without ab-
dominal pain or fever. Embryonal carcinoma may secrete
estrogen and can present with precocious puberty or ir-
regular vaginal bleeding [7]. The gross appearance varies
according to the individual constituents of the tumour. Im-
aging modalities can be used to establish the diagnosis but
different types of tumour may show overlapping features
and the definitive diagnosis is made by histopathology. In
this case very high levels of tumour markers AFP and hCG
could be attributed to EST and embyonal carcinoma, but
we could not find any evidence of dysgerminoma compo-
nent on histopathology as LDH was also highly raised. Im-
munohistochemistry is a wide-used biological technique
that help in the diagnosis and development of new man-
agement modalities [8,9]. Trinh DT et al. described the
utility of CD117, CD133, SALL4, OCT4, TCL1 and
glypican-3 in malignant germ cell tumors of the ovary [9].
Ovarian endodermal sinus tumours are highly aggres-
sive but with surgery and combination chemotherapy,
the five year survival with stage 1 tumours and more ad-
vanced disease are 92% and 29% to 44% respectively
[10]. Embryonal carcinoma of ovary is usually present
along with other components. Survival in embryonal
Figure 2 Yolk sac tumour. Yolk sac tumour showing reticular (a) and microcystic (b) areas with Schiller-Duval bodies (c). showingmultinucleated
trophoblastic giant cells (d).
Figure 3 Mixed germ cell tumour. Showing mature teratomatous components in the form of squamous islands (a), cystic spaces lined by
mucinous epithelium (c) and hepatocytes (b). Some areas also showed embryonal carcinoma (d).
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39%, with 50% of stage I patients being disease free at
3.75 to 15 years post-surgery and chemotherapy [11].
More recent data illustrate the improved survival achiev-
able with conservative surgery and combination chemo-
therapy, with survival figures of 98% and 94% for early
and advanced stage tumours [12]. Although standard
prognostic system for ovarian germ cell tumour is cur-
rently unavailable but poor prognostic indicators include
large size, unfavourable histological type, and advanced
stage at presentation. Elevation of both AFP and hCG
levels is a strong predictor of poor survival shown in a
recent analysis [13]. Unilateral oophorectomy and surgi-
cal staging is the minimal surgery in ovarian germ cell
tumour if conservation of fertility is of concern. Preser-
vation of fertility is recommended even in metastatic
disease as these tumours are highly sensitive to chemo-
therapy. Hysterectomy and bilateral salpingioophorect-
omy do not change the outcome [8]. All patients except
those with FIGO stage 1a require combination chemo-
therapy. Usually 3 to 4 course of combination chemo-
therapy containing bleomycin, etoposide and cisplatin
(BEP) or vincristine, dactinomycin, and cylophospha-
mide (VAC) are commonly used. The serum markers,
may become negative during chemotherapy, but this
may reflect regression of only a particular component of
the mixed lesion. Therefore, in these patients a second-
look laparotomy may be indicated if there is residual dis-
ease following chemotherapy.
Conclusion
Malingnant mixed germ cell tumours of ovary are highly
aggressive neoplasm and early intervention and fertility
sparing surgery is required for any adolescent girl pre-
senting with rapidly enlarging pelvic mass.
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